KalshiVerfügbarkeit prüfenKYC erforderlich2% GebührVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle implizite Wahrscheinlichkeit
COVID-19 14%Führend unter 6 Optionen
Marktqualitat
52 / 100
Mittlere Qualität24h-Volumen
0,9 €
Liquidität
5102,7 €
Mittlere LiquiditätSpread
2.0 pt
Enger SpreadMarktdaten
Aktualisiert vor 11 Minuten
27. Jan. 26, 01:00 UTC1. Jan. 27, 15:00 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
The anti-vax market: Which vaccines become less available in the US, 2025-2026
Manifold MarketsWill GiveWell recommend a grant to support breastfeeding promotion before 2027?
Manifold MarketsWill FDA approve more than 10 new mRNA based vaccines before 2028?
Manifold MarketsMeasles cases in U.S. in 2026?
PolymarketNew pandemic in 2026?
PolymarketHantavirus pandemic in 2026?
PolymarketRegeln
If the CDC ends its recommendation completely for the COVID-19 vaccine before Jan 1, 2027, then the market resolves to Yes.
Abwicklung über:CDC
- Merely reducing the categories of persons that it recommends the vaccine for, without reducing those categories to zero, is not encompassed by the Payout Criterion.
- If the CDC ends its recommendation completely for the Dengue vaccine before Jan 1, 2027, then the market resolves to Yes.
- If the CDC ends its recommendation completely for the the named outcome vaccine before Jan 1, 2027, then the market resolves to Yes.
- If the CDC ends its recommendation completely for the Influenza vaccine before Jan 1, 2027, then the market resolves to Yes.
- If the CDC ends its recommendation completely for the Polio vaccine before Jan 1, 2027, then the market resolves to Yes.
Offene Märkte
Health & MedicinePOLYMARKETMeasles cases in U.S. in 2026?
- ↑500+0.1pt100%
- ↑1k+0.1pt100%
- ↑2k+0.2pt100%
+9 weitere Ergebnisse
- Gesamtvolumen
- 6,9 Mio. €
- 24h-Volumen
- 28.124,7 €
POLYMARKETHantavirus pandemic in 2026?
- No97%
- Yes3%
- Gesamtvolumen
- 15,8 Mio. €
- 24h-Volumen
- 21.510 €
POLYMARKETNew pandemic in 2026?
- No-0.5pt93.1%
- Yes+0.5pt6.9%
- Gesamtvolumen
- 944.924,6 €
- 24h-Volumen
- 8176,6 €
KALSHIWhich countries will report an Ebola disease case before October?
- Kenya14%
- India6%
- Ethiopia-2.0pt5%
+13 weitere Ergebnisse
- Gesamtvolumen
- 22.382,9 €
- 24h-Volumen
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 600061%
+2 weitere Ergebnisse
- Gesamtvolumen
- 882.869,7 €
- 24h-Volumen
- 1674,1 €
KALSHIWill 3 mg THC beverages qualify as hemp under federal law?
- On Nov 13, 202696%
- On Mar 13, 202789%
- On Nov 19, 202786%
+1 weitere Ergebnisse
- Gesamtvolumen
- 16.329,9 €
- 24h-Volumen
- 1316,5 €
- Will 3 mg THC beverages be federally legal to sell?
- Will WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- When will the FDA approve Compass Pathways' COMP360 Psilocybin?
- Cyclosporiasis cases reported in the US in 2026?
- Pandemic in 2026?
- Ebola pandemic in 2026?
- Will the FDA approve any psychedelic substance for medical use this year?
- Hantavirus vaccine in 2026?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- FDA approves skin cancer vaccine by which date?
- How many gonorrhea cases will be reported in the United States in 2026?
Häufige Fragen
- Wie stehen die aktuellen Quoten für Which vaccines will the CDC no longer recommend in 2026??
- Kalshi bewertet COVID-19 mit 14% (Stand: 15. September 2026).
- Wann wird Which vaccines will the CDC no longer recommend in 2026? entschieden?
- Which vaccines will the CDC no longer recommend in 2026? soll am 1. Januar 2027 entschieden werden.
- Wie wird Which vaccines will the CDC no longer recommend in 2026? abgerechnet?
- Kalshi rechnet diesen Markt wie folgt ab: If the CDC ends its recommendation completely for the COVID-19 vaccine before Jan 1, 2027, then the market resolves to Yes.